Oregon Cancer Genomics Surveillance Program:
Translation of Genomics Applications into Healthcare Practice
One of the major efforts being undertaken by the Oregon Genetics Program is developing, implementing, and evaluating a three year, CDC-funded surveillance program to monitor the use of cancer-specific evidence-based genomic tests and family history in Oregon. These surveillance activities will target Oregon’s 2.9 million adults and Oregon healthcare providers (HCPs) working in a number of different clinical settings. The objectives of this program are to:
- Evaluate how familial risk of colorectal, breast and ovarian cancer influences Oregon healthcare practice and Oregonians' behavior
- Evaluate Oregonians' awareness, knowledge, and use of BRCA 1 & 2 testing
- Evaluate Oregon healthcare providers' knowledge, attitudes, and use of genomic tests for colorectal, breast, and ovarian cancer
- Evaluate disparities in Oregonians' access to genetic testing and genetic counseling for colorectal, breast, and ovarian cancer
Behavioral Risk Factor Surveillance System (BRFSS), Medicaid claims, Oregon State Cancer Registry, and genetics services data are being used, in addition to information gathered from HCPs to assess knowledge, attitudes, and use of genomic tests. HCPs in urban, rural, safety net, and private insurance settings will be surveyed to identify disparities in access to genomic testing and genetic counseling services. At the end of the project, we will report surveillance findings on the use of genomic tests and family history for colorectal, breast, and ovarian cancer and how the findings influence provider practice and patient behavior. This report will also include healthcare provider education recommendations.